September 12, 2024
CPHI Milan; 8-10 October
2024
2023
2022
2021
2020
2019
2018
2016
Latest news
September 27, 2024
EURETINA’24 Barcelona
September 2, 2024
Miklós Bodánszky Award
July 1, 2024
European Peptide Symposium 2024
June 19, 2024
IOPC Conference in Milan
June 14, 2024
RETISOM, a pioneering project!
June 12, 2024
Join BCN Peptides at CPhI China 2024!
May 21, 2024
We are delighted to announce our participation in BIO 2024 in San Diego!
May 13, 2024
We’re thrilled to announce our participation in TIDES USA 2024!
April 15, 2024
Join us at In-Cosmetics on April 16th to 18th in Paris!
January 18, 2024
Meet us in BIO-Europe Spring, from 18-20th March here in Barcelona!
January 17, 2024
Join us in DCAT on March 19th to 21st in New York!
January 16, 2024
Successful regulatory inspections and GMP renewal
October 23, 2023
Join BCN Peptides at CPhI Worldwide, at Booth 4C49, held in Barcelona from October 24th to 26th. Don’t hesitate to contact us to schedule a meeting!
September 21, 2023
Antonio Parente, awarded with the Trifermed Award for social impact in healthcare
September 7, 2023
Deeply committed to Environmental sustainability
July 3, 2023
Schedule a meeting with BCN Peptides at Chem Outsourcing (New Jersey, 6th-8th September)! Get to know us better!
July 3, 2023
Join BCN Peptides at CPhI SEA South East Asia, Booth H73, held in Bangkok from July 12th to 14th. Don’t hesitate to contact us to schedule a meeting!
May 2, 2023
BCNpeptides was in Tides convention at San Diego from 7th to 10th of May 2023
April 17, 2023
BCNpeptides was in CPhI Japan at booth 5K-19 from 19th to 21st of March 2023
March 28, 2023
9th Cataloniabio & Healthtech event
March 23, 2023
BCNpeptides was in DCAT Week at New York from 20th to 23rd of March 2023.
February 23, 2023
SARS-COV-2 peptide tools available!
November 22, 2022
BCN Peptides and Vall d’Hebron demonstrate the efficacy of a new drug to prevent metastasis.
March 26, 2021
BCNpeptides put forward a new potential therapy for the treatment of inflammatory bowel disease (Crohn disease and ulcerative colitis).
April 1, 2020
BCNpeptides, a partner of the European Consortium for the use of SOLNATIDE in COVID-19 patients.
September 4, 2019
BCN Peptides R&D on Atopic Dermatitis.
March 12, 2019
CataloniaBio & HealthTech awards prize recognizing Dr. Antonio Parente´s professional career.
December 20, 2018
Nature publication First-in-Human Personalized Therapeutic Vaccine for Brain Cancer.
February 1, 2016
BCN Peptides R&D on lysosomal storage diseases.
February 1, 2016
BCN Peptides iniciates a collaboration with IDP-Pharma.